Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 18 03:37PM ET
0.8350
Dollar change
-0.0750
Percentage change
-8.24
%
Index- P/E- EPS (ttm)-0.62 Insider Own34.68% Shs Outstand56.84M Perf Week-16.50%
Market Cap58.30M Forward P/E- EPS next Y-0.50 Insider Trans-0.02% Shs Float45.60M Perf Month-29.24%
Income-44.24M PEG- EPS next Q-0.15 Inst Own11.80% Short Float2.82% Perf Quarter-13.02%
Sales11.03M P/S5.29 EPS this Y13.44% Inst Trans-5.17% Short Ratio17.66 Perf Half Y-57.61%
Book/sh1.17 P/B0.71 EPS next Y6.83% ROA-38.76% Short Interest1.29M Perf Year-39.49%
Cash/sh1.09 P/C0.77 EPS next 5Y- ROE-42.51% 52W Range0.91 - 3.28 Perf YTD-25.45%
Dividend Est.- P/FCF- EPS past 5Y- ROI-52.42% 52W High-74.54% Beta0.76
Dividend TTM- Quick Ratio9.39 Sales past 5Y275.41% Gross Margin43.12% 52W Low-7.88% ATR (14)0.08
Dividend Ex-Date- Current Ratio10.14 EPS Y/Y TTM40.27% Oper. Margin-436.14% RSI (14)31.04 Volatility6.03% 7.01%
Employees131 Debt/Eq0.00 Sales Y/Y TTM61.90% Profit Margin-401.00% Recom2.33 Target Price1.30
Option/ShortYes / Yes LT Debt/Eq0.00 EPS Q/Q19.46% Payout- Rel Volume2.52 Prev Close0.91
Sales Surprise-27.54% EPS Surprise17.04% Sales Q/Q88.62% EarningsMar 21 AMC Avg Volume72.83K Price0.83
SMA20-17.30% SMA50-21.75% SMA200-46.39% Trades Volume173,161 Change-8.24%
Date Action Analyst Rating Change Price Target Change
Aug-11-22Downgrade Wells Fargo Overweight → Equal Weight $8 → $2.40
May-31-22Initiated Evercore ISI Outperform $7
Apr-14-22Initiated Wells Fargo Overweight $8
Apr-17-24 09:00AM
Mar-21-24 08:53PM
05:25PM
04:05PM
Mar-12-24 09:00AM
04:30PM Loading…
Mar-07-24 04:30PM
Feb-28-24 04:30PM
Feb-21-24 09:00AM
Feb-01-24 08:00AM
Jan-09-24 09:00AM
Nov-29-23 07:07AM
Nov-20-23 09:00AM
Nov-16-23 09:00AM
Nov-12-23 10:10AM
Nov-09-23 04:05PM
09:15AM Loading…
Nov-02-23 09:15AM
Oct-19-23 04:05PM
Oct-10-23 04:05PM
Oct-09-23 09:00AM
Sep-07-23 04:05PM
Aug-14-23 04:05PM
Aug-09-23 09:00AM
Jul-24-23 04:05PM
Jul-18-23 04:05PM
Jul-11-23 09:00AM
Jun-08-23 09:00AM
May-18-23 09:00AM
May-11-23 04:05PM
Apr-20-23 04:05PM
Mar-21-23 04:05PM
08:55AM Loading…
Mar-06-23 08:55AM
Feb-28-23 08:55AM
Feb-21-23 08:55AM
Feb-13-23 08:55AM
Feb-09-23 04:10PM
Feb-08-23 04:05PM
Feb-06-23 06:31PM
Nov-22-22 04:05PM
Nov-10-22 04:05PM
Oct-27-22 04:10PM
Oct-06-22 09:00AM
Sep-07-22 08:30AM
Aug-24-22 04:10PM
Aug-15-22 06:11AM
Aug-10-22 04:05PM
Jul-20-22 04:15PM
Jul-14-22 09:00AM
Jun-29-22 04:05PM
Jun-18-22 08:10AM
08:07AM
Jun-14-22 04:10AM
May-25-22 04:10PM
May-11-22 04:05PM
May-03-22 12:15PM
10:31AM
Apr-20-22 04:05PM
Mar-31-22 06:18PM
Mar-23-22 04:05PM
Mar-03-22 09:00AM
Mar-01-22 04:10PM
Feb-16-22 08:00AM
Feb-08-22 08:00AM
Feb-07-22 05:38PM
Jan-19-22 08:00AM
Jan-10-22 07:30AM
Jan-04-22 08:30AM
Hyperfine, Inc. is a medical device development company, which engages in providing imaging and monitoring through magnetic resonance imaging to revolutionize healthcare for people. It also develops imaging of health conditions through its Swoop portable magnetic resonance. The company was founded by Jonathan M. Rothberg and Ronald Walsworth on February 25, 2014 and is headquartered in Guilford, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TEISSEYRE THOMASChief Operating OfficerFeb 16 '24Sale1.113,2303,58596,526Feb 16 04:06 PM
TEISSEYRE THOMASChief Operating OfficerNov 16 '23Sale1.262,6553,34599,756Nov 17 07:34 PM
TEISSEYRE THOMASChief Operating OfficerAug 16 '23Sale2.262,7856,294102,411Aug 17 04:45 PM
Siddiqui KhanCMO and Chief Strategy OfficerAug 16 '23Sale2.261,7293,90876,981Aug 17 04:44 PM
Siddiqui KhanCMO and Chief Strategy OfficerMay 16 '23Sale1.251,7352,16978,710May 16 06:15 PM